Prices delayed by at least 15 minutes | Print
Biopharma Credit PLC (BPCR)
ORD USD0.01Open
$0.88
Previous close
$0.882
Trade high
$0.885
Estimated NAV
1.00134
Year high
$1.0094
Year low
$0.80
Premium / Discount
-11.92%
Market capitalisation
$994.37 mn
Volume
8,745
Dividend yield
6.93%
Ongoing charge
1.01%
ISIN
GB00BDGKMY29
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Before investing please read:
Share price
Dividends
| Previous | Latest | |
|---|---|---|
| Record date | 04/04/2025 | 27/06/2025 |
| Ex-dividend date | 03/04/2025 | 26/06/2025 |
| Payment date | 07/05/2025 | 31/07/2025 |
| Amount | $0.0175 | $0.0175 |
Net asset value (NAV)
| Estimated NAV | 1.00 |
|---|---|
| Latest actual NAV | 1.01 |
| Latest actual NAV date | 31 May 2025 |
| 12m average premium/discount | -11.65% |
Top 10 holdings
| Holdings 31/12/2024 | % of assets |
|---|---|
| Collegium Pharmaceutical Inc | 23.96 |
| Insmed Inc | 18.51 |
| BioCryst Pharmaceuticals Inc | 10.96 |
| OptiNose Inc | 6.15 |
| Evolus Inc | 5.29 |
| Geron Corp | 4.23 |
| NovoCure Ltd | 4.23 |
| UroGen Pharma Ltd | 4.23 |
| BioPharma Credit PLC | 4.07 |
| Tarsus Group PLC | 3.17 |
Investment objective
To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The Company will seek to achieve its investment objective predominantly through direct or indirect exposure to Debt Assets, which include Royalty Investments, Senior Secured Debt, Unsecured Debt and Credit Linked Notes.
Morningstar ratingTM
Morningstar sustainability ratingTM
News
Recent trades
| Date | Time | Price | Quantity | Value |
|---|---|---|---|---|
| 17/07/2025 | 08:31:41 | 0.8805 | 3,500 | 3,081.75 |
| 17/07/2025 | 08:10:45 | 0.884 | 10 | 8.84 |
| 17/07/2025 | 08:09:03 | 0.885 | 735 | 650.48 |
| 17/07/2025 | 08:04:54 | 0.88 | 4,500 | 3,960.00 |
| 16/07/2025 | 04:36:15 | 0.882 | 6,935 | 6,116.67 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.